These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34151999)
1. Golgi a-mannosidase II mediates the formation of vascular smooth muscle foam cells under inflammatory stress. Zha K; Ye Q Folia Histochem Cytobiol; 2021; 59(2):134-143. PubMed ID: 34151999 [TBL] [Abstract][Full Text] [Related]
2. Difference in LDL receptor feedback regulation in macrophages and vascular smooth muscle cells: foam cell transformation under inflammatory stress. Ye Q; Lei H; Fan Z; Zheng W; Zheng S Inflammation; 2014 Apr; 37(2):555-65. PubMed ID: 24297394 [TBL] [Abstract][Full Text] [Related]
3. Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation. Zhou C; Lei H; Chen Y; Liu Q; Li LC; Moorhead JF; Varghese Z; Ruan XZ PLoS One; 2013; 8(10):e75650. PubMed ID: 24146768 [TBL] [Abstract][Full Text] [Related]
4. Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation. Li LC; Varghese Z; Moorhead JF; Lee CT; Chen JB; Ruan XZ Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H874-84. PubMed ID: 23335792 [TBL] [Abstract][Full Text] [Related]
5. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro. Yuan Y; Zhao L; Chen Y; Moorhead JF; Varghese Z; Powis SH; Minogue S; Sun Z; Ruan XZ Am J Physiol Renal Physiol; 2011 Jul; 301(1):F236-43. PubMed ID: 21511699 [TBL] [Abstract][Full Text] [Related]
7. Sirolimus inhibits endogenous cholesterol synthesis induced by inflammatory stress in human vascular smooth muscle cells. Ma KL; Varghese Z; Ku Y; Powis SH; Chen Y; Moorhead JF; Ruan XZ Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1646-51. PubMed ID: 20348217 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation. Ye Q; Chen Y; Lei H; Liu Q; Moorhead JF; Varghese Z; Ruan XZ Inflamm Res; 2009 Nov; 58(11):809-18. PubMed ID: 19533020 [TBL] [Abstract][Full Text] [Related]
9. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530 [TBL] [Abstract][Full Text] [Related]
10. Structural investigation of the binding of 5-substituted swainsonine analogues to Golgi alpha-mannosidase II. Kuntz DA; Nakayama S; Shea K; Hori H; Uto Y; Nagasawa H; Rose DR Chembiochem; 2010 Mar; 11(5):673-80. PubMed ID: 20209559 [TBL] [Abstract][Full Text] [Related]
11. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia. Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609 [TBL] [Abstract][Full Text] [Related]
12. Structure-guided design of C3-branched swainsonine as potent and selective human Golgi α-mannosidase (GMII) inhibitor. Koemans T; Bennett M; Ferraz MJ; Armstrong Z; Artola M; Aerts JMFG; Codée JDC; Overkleeft HS; Davies GJ Chem Commun (Camb); 2024 Oct; 60(82):11734-11737. PubMed ID: 39318342 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Ruan XZ; Moorhead JF; Tao JL; Ma KL; Wheeler DC; Powis SH; Varghese Z Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1150-5. PubMed ID: 16543490 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines. Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199 [TBL] [Abstract][Full Text] [Related]
15. Ring finger protein 5 activates sterol regulatory element-binding protein 2 (SREBP2) to promote cholesterol biosynthesis via inducing polyubiquitination of SREBP chaperone SCAP. Kuan YC; Takahashi Y; Maruyama T; Shimizu M; Yamauchi Y; Sato R J Biol Chem; 2020 Mar; 295(12):3918-3928. PubMed ID: 32054686 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress. Wang X; Ma X; Zeng Y; Xu L; Zhang M Sci Rep; 2023 Nov; 13(1):19438. PubMed ID: 37945738 [TBL] [Abstract][Full Text] [Related]
17. [The effects of failure of low density lipoprotein receptor expression induced by inflammation on radial artery foam cell formation in patients with end-stage renal disease]. Ma KL; Liu J; Gao M; Ni J; Zhang Y; Zhang XL; Liu H; Huang HQ; Chen L; Wang YL; Liu BC Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):464-8. PubMed ID: 24059991 [TBL] [Abstract][Full Text] [Related]
18. Swainsonine, a potent mannosidase inhibitor, elevates rat liver and brain lysosomal alpha-D-mannosidase, decreases Golgi alpha-D-mannosidase II, and increases the plasma levels of several acid hydrolases. Tulsiani DR; Touster O Arch Biochem Biophys; 1983 Jul; 224(2):594-600. PubMed ID: 6408990 [TBL] [Abstract][Full Text] [Related]
19. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Xue JH; Yuan Z; Wu Y; Liu Y; Zhao Y; Zhang WP; Tian YL; Liu WM; Liu Y; Kishimoto C Cardiovasc Res; 2010 Apr; 86(1):141-50. PubMed ID: 20007688 [TBL] [Abstract][Full Text] [Related]
20. Poria cocos polysaccharides attenuated ox-LDL-induced inflammation and oxidative stress via ERK activated Nrf2/HO-1 signaling pathway and inhibited foam cell formation in VSMCs. Zhao J; Niu X; Yu J; Xiao X; Li W; Zang L; Hu Z; Siu-Po Ip P; Li W Int Immunopharmacol; 2020 Mar; 80():106173. PubMed ID: 31945610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]